# Tebipenem Pivoxil Hydrobromide (Tebipenem Pivoxil Hydrobromide) by Meiji Seika Pharma Co., Ltd.: new drug for further processing listing

**Launch Signal Score:** 15/100

| Field | Value |
|---|---|
| Generic name | Tebipenem Pivoxil Hydrobromide |
| NDC | 12543-0001 |
| Labeler | Meiji Seika Pharma Co., Ltd. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Approval pathway | DRUG FOR FURTHER PROCESSING |
| Dosage form | TABLET, FILM COATED |
| Active ingredients | TEBIPENEM PIVOXIL HYDROBROMIDE 300 mg/1 |
| Marketing start | 2026-10-01 |
| Package configurations | 1 |

## Why this score


Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=12543-0001). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.